Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination.
Streptococcus pneumonia
children
invasive pneumococcal disease
pneumococcal conjugate vaccine
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
04
2021
accepted:
28
12
2021
entrez:
11
2
2022
pubmed:
12
2
2022
medline:
15
2
2022
Statut:
epublish
Résumé
Streptococcus pneumonia is a common bacterium that can cause several types of infections, including invasive infections especially in children aged <5 years. The aim of this work is to report the different aspects of invasive pneumococcal disease (IPD) in a pediatric hospital in Casablanca, Morocco 4 years after the implementation of pneumococcal vaccination. We conducted a descriptive, retrospective study over a 4-year period from January 2015 to December 2018 in A. Harouchi Pediatric Hospital in Casablanca. This study included hospitalized children aged 0 to 14 years´ old who had an IPD. The data was collected using a data collection sheet from archived patient records and computerized laboratory database; organization of data was done using Microsoft Excel 2016 and analysis was done using SPSS-20. A total of 68 patients were included in this series over the 4-year period. Meningitis was the most common IPD (54.41%) followed by bacteremia (19.17%) and then pneumonia (16.17%). Of the 35 serogrouped strains, 7 were included in the pneumococcal conjugate vaccine (PCV) 10 (20%), 6 were PCV13-nonPCV10 serotypes (17.14%) and 6 were non-vaccine serotypes (17.14%). Among the strains tested for their antibiotic resistance profile, 32.70% were resistant to penicillin, tetracycline (29.78%), erythromycin (20.75%) and cotrimoxazole (17.31%). One strain was intermediate to ceftriaxone. The evolution was unfavorable for 18 patients (26.47%). This study reported high resistance rates to penicillin, tetracyclin and erythromycin. The mortality essentially concerned meningitis patients. Ongoing surveillance of antibiotic susceptibility and serotype distribution is needed by a national surveillance network.
Identifiants
pubmed: 35145594
doi: 10.11604/pamj.2022.41.2.29449
pii: PAMJ-41-2
pmc: PMC8797035
doi:
Substances chimiques
Pneumococcal Vaccines
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2Informations de copyright
Copyright: Amar Chikhaoui et al.
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Pediatr Infect Dis J. 2019 Apr;38(4):424-430
pubmed: 30882740
Lancet Glob Health. 2018 Jul;6(7):e744-e757
pubmed: 29903376
Med Mal Infect. 2015 Nov-Dec;45(11-12):463-9
pubmed: 26584841
Vaccine. 2020 Feb 11;38(7):1740-1745
pubmed: 31874778
Infect Drug Resist. 2018 Nov 26;11:2461-2469
pubmed: 30538512
Int J Infect Dis. 2015 Nov;40:95-101
pubmed: 26434380
Lancet Infect Dis. 2018 Aug;18(8):830-831
pubmed: 30001857
Clin Infect Dis. 2020 Jan 16;70(3):446-454
pubmed: 30869777
Lancet Neurol. 2018 Dec;17(12):1061-1082
pubmed: 30507391
J Clin Diagn Res. 2015 Jan;9(1):DD03-4
pubmed: 25737990
PLoS One. 2019 Jan 10;14(1):e0210081
pubmed: 30629620
Front Microbiol. 2016 Jun 14;7:803
pubmed: 27379023
Vaccine. 2017 Apr 4;35(15):1817-1827
pubmed: 28284682
Int J Infect Dis. 2019 Aug;85:135-140
pubmed: 31150842
Lancet Infect Dis. 2017 Nov;17(11):1133-1161
pubmed: 28843578